VINORELBINE PIERRE FABRE vinorelbine 80mg (as tartrate) capsule blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

vinorelbine tartrate, Quantity: 110.8 mg (Equivalent: vinorelbine, Qty 80 mg)

제공처:

Pierre Fabre Australia Pty Ltd

약제 형태:

Capsule, soft

구성:

Excipient Ingredients: ethanol; purified water; glycerol; macrogol 400; Gelatin; iron oxide yellow; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal

관리 경로:

Oral

패키지 단위:

1 tablet

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Non-small cell lung cancer: VINORELBINE PIERRE FABRE is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,Breast cancer: VINORELBINE PIERRE FABRE is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.

제품 요약:

Visual Identification: pale yellow, soft capsule printed N80.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Registered

승인 날짜:

2005-05-31